About US
Contact us
-
Sayonara, San Francisco. #JPM22 is going virtual, thanks to COVIDCancelled flights and hotel rooms have become par for the course during the COVID-19 pandemic. Now, with less than a month to go until the J.P. Morgan healthcare conference in January, the event orga2021/12/13
-
Eli Lilly trots out rosy 2022 projections, sees recent launches driving two-thirds of its businessEli Lilly said happy holidays to its shareholders on Wednesday morning,bumpingup its revenue projections for this year and next. While the top-line numbers bested analyst expectations, the company al2021/12/13
-
After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug AspaveliAfter rare disease drugmaker Sobi reportedly had a buyoutscupperedby pharma giant AstraZeneca, the company has picked up a win that stands to bolster its Aspaveli launch. England's National Institute2021/12/10
-
AstraZeneca's Evusheld becomes first FDA-authorized COVID antibody to protect the immunocompromised before exposurePeople in the U.S. with conditions that prevent them from building immunity with COVID-19 vaccines will soon have a way to get adequate protection from the virus. With the FDA’s emergency2021/12/10
-
As end of New York opioid trial nears, AbbVie's Allergan ponies up $200M to settle its part of the caseOn the day of closing arguments in a high-profile New York opioid trial, AbbVie has inked a $200 million settlement to put the case to bed. AbbVie's Allergan has agreed to pay New York state $200 mil2021/12/8
-
Pfizer, BioNTech say omicron partially evades its COVID vaccine but booster can restore protectionThe COVID-19 vaccine produced by Pfizer and BioNTech, Comirnaty, provides less protection against the omicron variant than it did against wild-type COVID and other variants, the companiessaidon Wedne2021/12/8
-
Pfizer, ex-employee reach a deal in COVID-19 vaccine trade secrets caseA now-former Pfizer employee is playing nice after the drugmaker sued her in November alleging the 15-year veteran uploaded more than 12,000 sensitive files—including documents on the company's wildl2021/12/6
-
Call for nominations: The Most Influential People in BiopharmaIn the two years since SARS-CoV-2 first emerged, biopharmaceutical companies have taken center stage in the global fight against the pandemic. Going forward, the industry appears poised to retain its2021/12/6
-
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the yearAmgen breathed a sigh of relief this summer when the Supreme Court declined to take up a Sandoz patent dispute challenging its anti-inflammatory blockbuster Enbrel. Now, the California drugmaker has2021/12/2
-
Merck's COVID-19 antiviral narrowly clears FDA panel—but committee echos support for revoking nod in favor of superior optionMerck and Ridgeback’s recent report that its antiviral molnupiravir wasn’t nearly as effective as previously indicated put a damper on enthusiasm that agame-changing oral treatment for COVID-19 was n2021/12/2